Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Ascentage Pharma Enters Clinical Collaboration to Evaluate the Combination of Bcl-2 and BTK Inhibitors

Monday, June 22, 2020

Ascentage Pharma HK a global clinicalstage biotechnology company engaged in developing novel therapies for cancers chronic hepatitis B CHB and senescence diseases today announced a clinical collaboration with Acerta Pharma the hematology research and...

Neurocline Biosciences and Takeda announce collaboration to develop and commercialize drug candidates for mental illness

Monday, June 22, 2020

Neurocline Biosciences and Takeda Pharmaceutical Co Ltd announced a strategic collaboration to develop and commercialize compounds in the early to midstage development of Takedas pipeline for mental illness Specifically Takeda has monopolized Neurocl...

Ovid Therapeutics Receives FDA Rare Pediatric Disease Designation for OV101 for the Treatment of Angelman Syndrome

Saturday, June 20, 2020

Ovid Therapeutics Inc a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases today announced that the US Food and Drug Administration FDA has granted Rare Pediatric Disease Des...

Alpine Immune Sciences and AbbVie Announce Option and License Agreement for the Development and Commercialization of ALPN-101

Friday, June 19, 2020

Alpine Immune Sciences Inc a leading clinicalstage immunotherapy company focused on developing innovative treatments for cancer and autoimmuneinflammatory diseases and AbbVie Inc NYSE ABBV a researchbased global biopharmaceutical company today annou...

Sarepta Therapeutics and Selecta Biosciences Enter Into Research License and Option Agreement for Selecta’s ImmTOR Immune Tolerance Platform in Neuromuscular Diseases

Friday, June 19, 2020

Sarepta Therapeutics the leader in precision genetic medicine for rare diseases and Selecta Biosciences Inc announced that they have entered into a Research License and Option agreement granting Sarepta an option to license the rights to develop and...

ISA Pharmaceuticals Strengthens Strategic Immuno-Oncology Collaboration With Regeneron

Thursday, June 18, 2020

ISA Pharmaceuticals BV a private clinicalstage immunotherapy company announced plans to initiate a potentially pivotal clinical trial for the combination of ISAb and Libtayo cemiplimab in oropharyngeal cancer a type of headandneck cancer under its st...

Lassen Therapeutics Launches to Discover and Develop Novel Antibody Therapeutics Including Lead Program Targeting IL-11 to Treat Fibrosis and Oncology

Thursday, June 18, 2020

Lassen Therapeutics announced it has emerged from stealth and secured million in Series A financing to develop antibodies as potential treatments for fibrosis rare diseases and oncology The Series A financing was led by Frazier Healthcare Partners F...

Neurocrine Biosciences and Takeda Announce Collaboration to Develop and Market Potential Therapies for Psychiatric Disorders

Wednesday, June 17, 2020

Neurocrine Biosciences Inc and Takeda Pharmaceutical Company Limited announced a strategic collaboration for the development and marketing of compounds in the initial and intermediate phases of Takedas psychiatric pipeline Takeda has granted an excl...

Monopar and NorthStar Join Forces to Develop Radio-Immuno-Therapeutics (RITs) Targeting Severe COVID-19

Wednesday, June 17, 2020

Monopar Therapeutics Inc and NorthStar Medical Radioisotopes LLC Beloit WI announced a collaboration to develop potential RadioImmunoTherapeutics RITs to treat severe COVID patients with SARSCoV infection Monopar is a clinicalstage biopharmaceutical...

MedRhythms Receives FDA Breakthrough Device Designation for Chronic Stroke Digital Therapeutic

Tuesday, June 16, 2020

MedRhythms a Portland Mainebased digital therapeutics company that is building direct stimulation prescription digital therapeutics that use sensors music and software to improve walking impairments announced today that it has received Breakthrough D...